Probi AB
STO:PROB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Probi AB
Capital Expenditures
Probi AB
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Probi AB
STO:PROB
|
Capital Expenditures
-kr56m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-17%
|
|
|
Biogaia AB
STO:BIOG B
|
Capital Expenditures
-kr3.6m
|
CAGR 3-Years
41%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
Bonesupport Holding AB
STO:BONEX
|
Capital Expenditures
-kr5.2m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
Vitrolife AB
STO:VITR
|
Capital Expenditures
-kr247m
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-65%
|
CAGR 10-Years
-27%
|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Capital Expenditures
-kr3.2B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-36%
|
|
|
BioArctic AB
STO:BIOA B
|
Capital Expenditures
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Probi AB
Glance View
Probi AB engages in the development and sale of probiotics. The company is headquartered in Lund, Skane and currently employs 175 full-time employees. The Company’s activities are divided into two business areas: Functional Foods, which focuses on the probiotics application in food in partnership with food companies; and Consumer Healthcares, which develops, commercializes and sells Probi probiotics in collaboration with a range of entities, such as pharmaceutical companies and firms related to the production of probiotics and self-care goods. Its brands portfolio comprises two trademarks: Probi Digestis and Probi Defendum. The firm's partners include Danone, Skanemejerier, NextFoods, Sanum Polska, Heinz, Kraft Foods, and Institut Rosell, among others. The firm is a parent of Probi Food AB and Probi Feed AB.
See Also
What is Probi AB's Capital Expenditures?
Capital Expenditures
-56m
SEK
Based on the financial report for Sep 30, 2024, Probi AB's Capital Expenditures amounts to -56m SEK.
What is Probi AB's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-17%
Over the last year, the Capital Expenditures growth was 0%. The average annual Capital Expenditures growth rates for Probi AB have been -12% over the past three years , -14% over the past five years , and -17% over the past ten years .
